The table below shows Eton Pharmaceuticals, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$24.27M
$22.46M
$18.93M
$17.28M
$10.32M
$9.07M
Cost of revenue
$9.53M
$14.60M
$7.00M
$7.42M
$4.02M
$3.45M
Gross profit
$14.73M
$7.86M
$11.92M
$9.86M
$6.30M
$5.63M
R&D
$1.88M
$1.11M
$3.71M
$1.16M
$505.00K
$2.97M
ETON annual revenue (10-K history)
Eton Pharmaceuticals, Inc. reported annual revenue of $79.95M for fiscal year 2025. That is up 104.9% from $39.01M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $959.00K (FY 2019) to $79.95M. Figures come from the company's audited annual reports as filed with the SEC.